Novartis Sues Par Over Dementia Patch Generic

Novartis Sues Par Over Dementia Patch Generic

Novartis AG hit rival Par Pharmaceutical Inc. with a suit in Delaware federal court Thursday, accusing Par’s proposed generic version of dementia treatment Exelon of infringing a patent covering the drug. ...read more

  • Tags: